WS #13445

From 498 msgs · 5 key-dev
Holding: newest synthesis is 97d 18h old

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Novo Nordisk guidance and competition

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Full world state #13445 →